These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22086376)

  • 1. [Discontinuing oral anticoagulation for elective surgical interventions].
    Marzan A; Ulrich Somaini S; Bächli E
    Praxis (Bern 1994); 2011 Nov; 100(23):1387-92; quiz 1393-5. PubMed ID: 22086376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are there guidelines for performance of coloscopy during drug anticoagulation?].
    Vogt W; Maier KP
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2333. PubMed ID: 14593580
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
    MMW Fortschr Med; 2005 Jun; 147(22):51. PubMed ID: 15977637
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perioperative heparin bridging is rarely indicated].
    Nielsen JD; Münster AM; Husted SE
    Ugeskr Laeger; 2016 Feb; 178(9):V12150952. PubMed ID: 26957485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of bridging anticoagulation.
    Patel JP; Arya R
    Br J Haematol; 2014 Mar; 164(5):619-29. PubMed ID: 24224681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.
    Spyropoulos AC
    Dis Mon; 2005; 51(2-3):183-93. PubMed ID: 15900271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding low INR in clinical practice.
    Hylek EM; Rose AJ
    Thromb Haemost; 2009 Mar; 101(3):417-8. PubMed ID: 19277399
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting oral anticoagulation.
    Weiner M
    Clin Pharmacol Ther; 2000 Jul; 68(1):4-5. PubMed ID: 10945309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
    Dempfle CE; Borggrefe M
    Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Rickli H; Maeder MT
    Ther Umsch; 2016; 73(10):589-594. PubMed ID: 28045361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Graf L; Korte W
    Ther Umsch; 2016; 73(10):545-549. PubMed ID: 28045364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
    MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral anticoagulants.
    McGlasson DL
    Clin Lab Sci; 2004; 17(2):107-12. PubMed ID: 15168892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.